These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
935 related items for PubMed ID: 22114021
1. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Thomsen H, Steffensen E, Larsson EM. Acta Radiol; 2012 Feb 01; 53(1):95-101. PubMed ID: 22114021 [Abstract] [Full Text] [Related]
2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method. Cebeci H, Aydin O, Ozturk-Isik E, Gumus C, Inecikli F, Bekar A, Kocaeli H, Hakyemez B. Eur J Radiol; 2014 Oct 01; 83(10):1914-9. PubMed ID: 25087109 [Abstract] [Full Text] [Related]
3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. Clin Radiol; 2005 Apr 01; 60(4):493-502. PubMed ID: 15767107 [Abstract] [Full Text] [Related]
4. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R, Babb J, Law M, Pollack E, Johnson G. J Magn Reson Imaging; 2007 Oct 01; 26(4):1053-63. PubMed ID: 17896374 [Abstract] [Full Text] [Related]
5. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms. Provenzale JM, York G, Moya MG, Parks L, Choma M, Kealey S, Cole P, Serajuddin H. AJR Am J Roentgenol; 2006 Oct 01; 187(4):1036-42. PubMed ID: 16985154 [Abstract] [Full Text] [Related]
6. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Xu Q, Liu Q, Ge H, Ge X, Wu J, Qu J, Xu K. Medicine (Baltimore); 2017 Dec 01; 96(50):e9332. PubMed ID: 29390403 [Abstract] [Full Text] [Related]
7. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Pauliah M, Saxena V, Haris M, Husain N, Rathore RK, Gupta RK. Magn Reson Imaging; 2007 Nov 01; 25(9):1292-9. PubMed ID: 17490844 [Abstract] [Full Text] [Related]
8. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M. AJR Am J Roentgenol; 1998 Dec 01; 171(6):1479-86. PubMed ID: 9843274 [Abstract] [Full Text] [Related]
10. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma. Roy B, Awasthi R, Bindal A, Sahoo P, Kumar R, Behari S, Ojha BK, Husain N, Pandey CM, Rathore RK, Gupta RK. J Comput Assist Tomogr; 2013 Dec 01; 37(3):321-6. PubMed ID: 23673999 [Abstract] [Full Text] [Related]
11. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. Ellingson BM, Zaw T, Cloughesy TF, Naeini KM, Lalezari S, Mong S, Lai A, Nghiemphu PL, Pope WB. J Magn Reson Imaging; 2012 Jun 01; 35(6):1472-7. PubMed ID: 22281731 [Abstract] [Full Text] [Related]
12. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Eur J Radiol; 2006 Jun 01; 58(3):394-403. PubMed ID: 16527438 [Abstract] [Full Text] [Related]
13. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management]. Metellus P, Dutertre G, Mekkaoui C, Nanni I, Fuentes S, Ait-Ameur A, Chinot O, Dufour H, Figarella-Branger D, Cordoliani YS, Grisoli F. Neurochirurgie; 2008 Aug 01; 54(4):503-11. PubMed ID: 18573509 [Abstract] [Full Text] [Related]
14. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion. Law M, Brodsky JE, Babb J, Rosenblum M, Miller DC, Zagzag D, Gruber ML, Johnson G. J Magn Reson Imaging; 2007 Jun 01; 25(6):1113-9. PubMed ID: 17520715 [Abstract] [Full Text] [Related]
15. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Warmuth C, Gunther M, Zimmer C. Radiology; 2003 Aug 01; 228(2):523-32. PubMed ID: 12819338 [Abstract] [Full Text] [Related]
16. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z. Acta Radiol; 2009 Mar 01; 50(2):217-25. PubMed ID: 19096950 [Abstract] [Full Text] [Related]
17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N, Dávila J, Medrano J, Olmos S. Eur J Radiol; 2008 Sep 01; 67(3):427-33. PubMed ID: 18442889 [Abstract] [Full Text] [Related]
18. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients. Hunsche S, Sauner D, Schreiber WG, Oelkers P, Stoeter P. J Magn Reson Imaging; 2002 Aug 01; 16(2):137-46. PubMed ID: 12203760 [Abstract] [Full Text] [Related]
19. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Sentürk S, Oğuz KK, Cila A. Diagn Interv Radiol; 2009 Mar 01; 15(1):3-12. PubMed ID: 19263367 [Abstract] [Full Text] [Related]
20. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique. Soni N, Dhanota DPS, Kumar S, Jaiswal AK, Srivastava AK. Neurol India; 2017 Mar 01; 65(5):1046-1052. PubMed ID: 28879895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]